Latest News and Press Releases
Want to stay updated on the latest news?
-
We are investigating the fairness of the sale of Surmodics to GTCR for $43.00 per share in cash
Want to stay updated on the latest news?
We are investigating the fairness of the sale of Surmodics to GTCR for $43.00 per share in cash